Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, October 24:
Amicus Therapeutics, Inc. FOLD: This biotechnology company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 10% over the last 60 days.
Amicus Therapeutics, Inc. price-consensus-chart | Amicus Therapeutics, Inc. Quote
Amicus Therapeutics' shares gained 10.2% over the last three months compared with the S&P 500’s advanced of 6.8%. The company possesses a Momentum Score of A.
Amicus Therapeutics, Inc. price | Amicus Therapeutics, Inc. Quote
Clipper Realty Inc. CLPR: This real estate company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 43.6% over the last 60 days.
Clipper Realty Inc. price-consensus-chart | Clipper Realty Inc. Quote
Clipper Realty's shares gained 68.2% over the last three months compared with the S&P 500’s advanced of 6.7%. The company possesses a Momentum Score of B.
Clipper Realty Inc. price | Clipper Realty Inc. Quote
Harrow, Inc. HROW: This eyecare pharmaceutical company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 164.3% over the last 60 days.
Harrow, Inc. price-consensus-chart | Harrow, Inc. Quote
Harrow's shares gained 127.2% over the last three months compared with the S&P 500’s advanced of 6.7%. The company possesses a Momentum Score of A.
Harrow, Inc. price | Harrow, Inc. Quote
See the full list of top ranked stocks here
Learn more about the Momentum score and how it is calculated here.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Amicus Therapeutics, Inc. (FOLD) : Free Stock Analysis Report
Clipper Realty Inc. (CLPR) : Free Stock Analysis Report
Harrow, Inc. (HROW) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.